Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Inhalte:

  • => Welche Forschungsthemen werden an der Medizinischen Universität bearbeitet?.
  • => Wer ist daran beteiligt und welche Methoden werden angewandt?.
  • => Welche Fördergeber unterstützen welche Projekte?.
  • => Wo werden Forschungsergebnisse publiziert?.

Facts and Figures: 2.708 Forscher*innenprofile (davon 1595 mit ORCID-ID), 9.139 Forschungsprojekte, 156.773 Publikationen, Posters und Vorträge, 65.571 Volltextlinks (davon Volltext frei zugänglich: > 28.904 (Open Access) )

Aktuelle Zitierungen im Web of Science: 2.038.792, davon 3.971 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 300.307

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Lichtkontrolle von Orai Ca2+ Oszillationen in GBM Zellen
Projektleitung: Schindl Rainer
Laufzeit: 01.03.2026 - 01.03.2029
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

TRP-vermittelte Kationen Signalwege TRPC.at
Projektleitung: Schindl Rainer
Laufzeit: 01.10.2026 - 30.09.2030
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):


27.01.2026:

Ortiz, A; Arici, M; Goumenos, DS; Adamczak, M; Eller, K; Ferreira, AC; Grandaliano, G; Jager, KJ; Lees, JS; Liakopoulos, V; Minutolo, R; Sezer, S; Azzolini, L; Fontana, M; Torres, F; Torra, R Randomised controlled trials in Europe: a call to action to protect national health care systems from the upcoming tsunami of kidney failure.
Nephrol Dial Transplant. 2026; Doi: 10.1093/ndt/gfag007
PubMed FullText FullText_MUG

 

27.01.2026:

Agrawal, D; Cisarova, K; Vosberg, S; Allmendinger, F; Munkhbaatar, E; Dandachi, N; Fernandez, Hernandez, FJ; Tonietto, M; Jäger, V; Anton, M; Keller, EC; Jesinghaus, M; Meinhardt, AL; Haefner, V; Stoeger, T; Steiger, K; McGranahan, N; Dengler, MA; Wahida, A; Jost, PJ Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.
Sci Adv. 2026; 12(4):eadz9227 Doi: 10.1126/sciadv.adz9227
PubMed FullText FullText_MUG

 

27.01.2026:

Pemberton, JS; Andrews, RC; Barnard-Kelly, K; Battelino, T; Danne, T; Heinemann, L; Kar, P; Lumb, A; Maahs, DM; Mader, JK; Mathieu, C; Mohan, V; Murphy, HR; Scott, EM; Sherr, JL; Smart, CE; Tauschmann, M; Williams, A; Wilmot, EG; Zaharieva, DP; Moser, O International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring.
Diabetes Obes Metab. 2026; Doi: 10.1111/dom.70460
PubMed FullText FullText_MUG

 

27.01.2026:

Jain, D; Wahidi, M; Effendi, J; Hoang, L; Terinte, C; Pesci, A; Kiyokawa, T; Alvarado-Cabrero, I; Oliva, E; Rakislova, N; Felix, A; Allison, D; Guerra, E; Roma, A; Fadare, O; Turashvili, G; Parra-Herran, C; Kir, G; Erbagci, A; Mills, A; Regauer, S; Ordi, J; Jang, H; Kim, S; Gogoi, R; Zannoni, GF; Mateoiu, C; Lastra, R; Devins, K; Horn, LC; McCluggage, WG; Stolnicu, S; Ali-Fehmi, R Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.
Gynecol Oncol. 2026; 205:89-98 Doi: 10.1016/j.ygyno.2026.01.012
PubMed FullText FullText_MUG

 

27.01.2026:

Wilson-Morkeh, H; Seluk, L; Bosch, P; Aguiar, C; Thiel, J; Hellmich, B; Wechsler, ME; Siddiqui, S Targeting Immunologic Pathways in Eosinophilic Granulomatosis With Polyangiitis: Translating Emerging Evidence Into Clinical Practice.
Allergy. 2026; Doi: 10.1111/all.70215
PubMed FullText FullText_MUG

 

25.01.2026:

Jais, P; Neuzil, P; Scherr, D; Frison, E; Knecht, S; Boveda, S; Deisenhofer, I; Maury, P; Deneke, T; Cochet, H; Rousset, M; Renaudeau, V; Sauer, E; Sermesant, M; Kautzner, J; Erhard, N; Wichterle, D Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial.
Eur Heart J. 2026; Doi: 10.1093/eurheartj/ehaf1115
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni Graz • Impressum